ZA793313B - A process for the preparation of a sterile injectable physiologically acceptable solution of an x-ray contrast agent and solutions of the x-ray contrast agent and a buffer - Google Patents

A process for the preparation of a sterile injectable physiologically acceptable solution of an x-ray contrast agent and solutions of the x-ray contrast agent and a buffer

Info

Publication number
ZA793313B
ZA793313B ZA793313A ZA793313A ZA793313B ZA 793313 B ZA793313 B ZA 793313B ZA 793313 A ZA793313 A ZA 793313A ZA 793313 A ZA793313 A ZA 793313A ZA 793313 B ZA793313 B ZA 793313B
Authority
ZA
South Africa
Prior art keywords
contrast agent
ray contrast
buffer
solutions
preparation
Prior art date
Application number
ZA793313A
Other languages
English (en)
Inventor
F Rakli
M Kelly
Original Assignee
Nyegaard & Co As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nyegaard & Co As filed Critical Nyegaard & Co As
Priority to IE1241/79A priority Critical patent/IE48437B1/en
Publication of ZA793313B publication Critical patent/ZA793313B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0452—Solutions, e.g. for injection
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/90—In vivo diagnostic or in vivo test agent which contains an additional ingredient to reduce the toxicity or side effects of the active ingredient

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
ZA793313A 1978-07-04 1979-07-03 A process for the preparation of a sterile injectable physiologically acceptable solution of an x-ray contrast agent and solutions of the x-ray contrast agent and a buffer ZA793313B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IE1241/79A IE48437B1 (en) 1978-07-04 1979-08-08 A process for the preparation of a sterile injectable physiologically acceptable solution of an x-ray contrast agent and solutions of the x-ray contrast agent and a buffer

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7828764 1978-07-04
KR1019790002214A KR830001643B1 (ko) 1978-07-04 1979-07-03 X-선 조영제의 생리적으로 허용되는 멸균 주사용 용액을 제조하는 방법

Publications (1)

Publication Number Publication Date
ZA793313B true ZA793313B (en) 1980-08-27

Family

ID=26268114

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA793313A ZA793313B (en) 1978-07-04 1979-07-03 A process for the preparation of a sterile injectable physiologically acceptable solution of an x-ray contrast agent and solutions of the x-ray contrast agent and a buffer

Country Status (22)

Country Link
US (2) US4278654A (fi)
JP (1) JPS5531068A (fi)
KR (1) KR830001643B1 (fi)
AR (1) AR222337A1 (fi)
AT (1) AT371998B (fi)
AU (1) AU523295B2 (fi)
BE (1) BE877443A (fi)
CA (1) CA1132901A (fi)
CH (1) CH649469A5 (fi)
DE (1) DE2926850C2 (fi)
DK (1) DK155714C (fi)
ES (1) ES8200082A1 (fi)
FI (1) FI75492C (fi)
FR (1) FR2435253A1 (fi)
HK (1) HK59984A (fi)
IT (1) IT1193761B (fi)
NL (1) NL183121C (fi)
NZ (1) NZ190907A (fi)
PT (1) PT69869A (fi)
SE (1) SE445971B (fi)
SG (1) SG5784G (fi)
ZA (1) ZA793313B (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3150916A1 (de) * 1981-12-18 1983-06-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen N-hydroxyaethylierte 2,4,6-trijodaminoisiophthalsaeure-bis- trihydroxybutylamide, deren herstellung und diese enthaltende roentgenkontrastmittel"
US4396598A (en) * 1982-01-11 1983-08-02 Mallinckrodt, Inc. Triiodoisophthalamide X-ray contrast agent
US5035877A (en) * 1985-08-09 1991-07-30 Cook Imaging Corporation Non-ionic contrast media from ionic contrast media
DE3689330T2 (de) * 1985-08-09 1994-05-19 Cook Imaging Corp Nichtionische polyolkontrastmittel aus ionischen kontrastmitteln.
US4718463A (en) * 1985-12-20 1988-01-12 Mallinckrodt, Inc. Method of producing prefilled sterile plastic syringes
US5847009A (en) * 1986-01-14 1998-12-08 Alliance Pharmaceutical Corp. Prophylaxis in the parenteral administration of particulate dispersions in fluorocarbon emulsions
US5284645A (en) * 1987-08-05 1994-02-08 Alliance Pharmaceutical Corp. Fluorocarbon emulsions containing amino acid based anti-inflamatory agents and buffer systems
US4863714A (en) * 1987-02-05 1989-09-05 Cook Imaging Corporation Sterilization of compositions of limited stability
IL94718A (en) * 1989-07-05 1994-10-21 Schering Ag Non-ionic carboxamide contrast agent and method of preparation
US5698739A (en) * 1989-07-05 1997-12-16 Schering Aktiengesellschaft Carboxamide non-ionic contrast media
US5075502A (en) * 1989-12-13 1991-12-24 Mallinckrodt, Inc. Nonionic x-ray contrast agents, compositions and methods
US5191120A (en) * 1989-12-13 1993-03-02 Mallinckrodt Medical, Inc. Process for preparing nonionic X-ray contrast agents
DE4111939A1 (de) * 1991-04-12 1992-10-22 Fresenius Ag Parenteral verabreichbare, hitzesterilisierbare o/w-emulsion eines roentgenkontrastmittels
US5169864A (en) * 1991-11-15 1992-12-08 Baxter International Inc. Unbuffered premixed ranitidine formulation
DE4316722A1 (de) * 1993-05-19 1994-11-24 Fresenius Ag Parenteral verabreichbare, unter Hitzesterilisationsbedingungen stabile O/W-Emulsion eines Röntgenkontrastmittels
PT876140E (pt) * 1996-01-25 2004-02-27 Schering Ag Solucoes para injeccao e perfusao concentradas e melhoradas para aplicacao intravascular
DE19648650C2 (de) * 1996-01-29 1998-07-02 Schering Ag Puffersysteme und deren Verwendung zur Stabilisierung pharmazeutischer Zubereitung
US6072069A (en) * 1998-11-04 2000-06-06 Biophysica, Inc. Biodegradable nonionic contrast media
US7250153B2 (en) * 2002-12-12 2007-07-31 Biophysica Research, Inc. Contrast media formulations having improved biological tolerance
BR112012023063A2 (pt) * 2010-03-23 2016-05-17 Ge Healthcare As processo para a preparação de uma composição para raio x, e, composição de diagnóstico para raio x
EP2854531A4 (en) * 2012-05-30 2016-03-23 Verrow Pharmaceuticals Inc STABILIZED FORMULATIONS CONTAINING IODIZED CONTRAST AGENTS AND CYCLODEXTRINS

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3758E (fr) * 1905-02-21 Jules Cesar Napoleon Fouilloy Collier d'attache pour protecteur antidérapant de pneumatiques
NL127881C (fi) * 1963-03-25
GB1069437A (en) * 1963-10-23 1967-05-17 Nyegaard & Co As Injectable x-ray contrast media
US3733397A (en) * 1966-12-02 1973-05-15 Pharmacia Ab Method for the x-ray visualization of body cavities and a preparation for carrying out the method
SE315975B (fi) * 1967-12-28 1969-10-13 Pharmacia Ab
GB1321591A (en) * 1969-06-27 1973-06-27 Nyegaard & Co As Non-ionic iodinated x-ray contrast agents
US4021481A (en) * 1969-06-27 1977-05-03 Nyegaard & Co. A/S Amido derivatives of 2,4,6-triiodobenzoic acids containing at least one N-hydroxyalkyl and at least two hydroxyl groups
CH583562A5 (fi) * 1973-07-17 1977-01-14 Bracco Ind Chimica Spa
GB1495679A (en) * 1974-06-17 1977-12-21 Mallinckrodt Inc Substituted isophthalamic acids
US3953497A (en) * 1974-07-29 1976-04-27 Mallinckrodt, Inc. 2,4,6-Triiodo-5-methoxyacetamido-N-methylisophthalamic acid and salts, acyl halides and esters thereof
GB1514920A (en) * 1974-10-09 1978-06-21 Reckitt & Colmann Prod Ltd Dispensing container for medicinal foams
FI760068A (fi) * 1975-02-03 1976-08-04 Schering Ag
DE2505218A1 (de) * 1975-02-05 1976-08-19 Schering Ag Neue orale roentgenkontrastmittel und verfahren zu ihrer herstellung
GB1548594A (en) * 1976-06-11 1979-07-18 Nyegaard & Co As Triiodoisophthalic acid amides
DE2629228C2 (de) * 1976-06-25 1984-10-18 Schering AG, 1000 Berlin und 4709 Bergkamen Jodierte Isophthalamsäure-Derivate Verfahren zu deren Herstellung sowie deren Verwendung
US4256729A (en) * 1979-03-23 1981-03-17 Mallinckrodt, Inc. N,N'-Bis-(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(2-keto-L-gulonamido)isophthalamide and radiological compositions containing same

Also Published As

Publication number Publication date
FR2435253A1 (fr) 1980-04-04
NL183121C (nl) 1988-08-01
NL7905166A (nl) 1980-01-08
AT371998B (de) 1983-08-25
AR222337A1 (es) 1981-05-15
SG5784G (en) 1985-02-01
DE2926850A1 (de) 1980-03-06
ES482131A0 (es) 1980-12-16
FI75492B (fi) 1988-03-31
DK280979A (da) 1980-01-05
SE445971B (sv) 1986-08-04
US4278654A (en) 1981-07-14
KR830000911A (ko) 1983-04-28
CH649469A5 (de) 1985-05-31
US4396597A (en) 1983-08-02
IT1193761B (it) 1988-08-24
DK155714C (da) 1989-10-30
FI792101A (fi) 1980-01-05
DK155714B (da) 1989-05-08
SE7905830L (sv) 1980-01-05
BE877443A (fr) 1980-01-03
AU4861579A (en) 1980-02-07
NZ190907A (en) 1981-10-19
HK59984A (en) 1984-08-10
JPS6210209B2 (fi) 1987-03-05
KR830001643B1 (ko) 1983-08-22
PT69869A (en) 1979-08-01
IT7949618A0 (it) 1979-07-03
FI75492C (fi) 1988-07-11
AU523295B2 (en) 1982-07-22
CA1132901A (en) 1982-10-05
DE2926850C2 (de) 1985-01-24
NL183121B (nl) 1988-03-01
FR2435253B1 (fi) 1984-03-16
JPS5531068A (en) 1980-03-05
ES8200082A1 (es) 1980-12-16
ATA464479A (de) 1983-01-15

Similar Documents

Publication Publication Date Title
SG5784G (en) A process for the preparation of a sterile injectable physiologically acceptable solution of an x-ray contrast agent and solutions of the x-ray contrast agent and a buffer
GB2017113B (en) Process for preparing a composition of a polymer and a physiologically active substance
DE3061347D1 (en) 2,4,6-triiodo-isophthalic acid derivatives, process for their preparation and x-ray contrast agents containing them
DE3060592D1 (en) Derivatives of 2,4,6-triodo-isophthalic acid, process for their preparation and x-ray contrast agents containing them
JPS5581649A (en) Polymer composition for medical treatment and its preparation
JPS5521987A (en) Tissue for sterilization
IL65080A (en) Bandage for administering beneficial drug
JPS52122632A (en) Medical composition and process for preparing same
DE2967611D1 (en) Device for tomographic examination of a body by x or gamma ray scanning
GB2028140B (en) Apparatus for sucking blood out of body cavities
DE2861672D1 (en) Somatostatin-like cyclopeptides, a process for their preparation, pharmaceutical compositions containing them, and their therapeutical application
JPS5579321A (en) Medical composition for local administration
DE2856901D2 (de) Form of implant medicament and preparation process
JPS545912A (en) Acidic citric acid alkali process for preparing same and medical for treating urochrome containing same
JPS53127497A (en) Novel pyroloquinoxaline process for preparing same and medical composition
JPS53121789A (en) Penicilline process for preparing and medical composition containing same
GB2031405B (en) Process for the preparation of a sterile injectable physiologically acceptable solution of an x-ray contrast agent and solutions of the x-ray contrast agent and a buffer
IL57713A0 (en) A process for the preparation of a sterile injectable physiologically acceptable solution of an x-ray contrast agent and solutions of the x-ray contrast agent and a buffer
JPS5519272A (en) Imidazoline derivative and medical composition
JPS552401A (en) Xxray apparatus for medical and dental use
DE2962080D1 (en) Alpha-n-acetyl-l-phenylalanine-l-arginine-ethyl ester, process for its preparation and its use as a diagnostic agent for kallikrein
JPS552402A (en) Xxray apparatus for medical and dental use
JPS55118745A (en) Preparation of collagen sheettlike substance for medical treatment
CH611148A5 (en) Endo-osseous implant used in odontostomatology (mouth surgery)
JPS54130502A (en) Physiological active substance*its manufacture and medical composition